The Department of Defense's Defense Logistics Agency Troop Support Medical awarded a $179,992.80 firm fixed-price delivery order to Genentech USA, Inc. to provide the antiviral medication oseltamivir phosphate. Genentech is a foreign-owned, for-profit manufacturer of pharmaceutical products. This order supports maintaining military medical readiness and was placed against an existing indefinite delivery contract. The contract has a completion date of September 12, 2018 and was awarded on September 12, 2017. No set-aside designation was used.